LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2018-2024)
The LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market would witness market growth of 31.0% CAGR during the forecast period (2018 – 2024). Minimally invasive glaucoma surgery (MIGS) devices are used to treat glaucoma to provide a safer and lesser invasive means of reducing intraocular pressure (IOP), as compared to conventional glaucoma surgery devices. MIGS devices would be most preferred surgical modality during the forecast period to treat glaucoma. It limits the dependency on conventional medications as well as cuts the complications associated with traditional procedures. Glaucoma is a progressive disease and is the major cause of irreversible blindness with an estimated burden to rise 111.8 million by 2040. This has increased the demand for MIGS devices in the treatment of glaucoma.
The factors driving the market include rapid rise in geriatric population, who are more prone to ophthalmology diseases such as glaucoma and cataract. The novel paradigm of glaucoma therapy by using MIGS devices will aspire to a much reduced dependence on topical medication. In addition, increasing preference of surgeons for MIGS is adding boost to the market growth.
On the basis of Surgery, the market is segmented into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma. Target is categorized into Trabecular Meshwork, Suprachoroidal Space and Other Targets. On the basis of Product, the market is segmented into MIGS Stents, MIGS Shunts and Other Products. The End Users covered under the report are Eye Hospitals, Ophthalmology Clinics and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Prominent players offering minimally invasive glaucoma surgery (MIGS) devices include Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.
The factors driving the market include rapid rise in geriatric population, who are more prone to ophthalmology diseases such as glaucoma and cataract. The novel paradigm of glaucoma therapy by using MIGS devices will aspire to a much reduced dependence on topical medication. In addition, increasing preference of surgeons for MIGS is adding boost to the market growth.
On the basis of Surgery, the market is segmented into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma. Target is categorized into Trabecular Meshwork, Suprachoroidal Space and Other Targets. On the basis of Product, the market is segmented into MIGS Stents, MIGS Shunts and Other Products. The End Users covered under the report are Eye Hospitals, Ophthalmology Clinics and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Prominent players offering minimally invasive glaucoma surgery (MIGS) devices include Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery
1.4.2 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Target
1.4.3 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
1.4.4 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End User
1.4.5 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Drivers, and Restraints
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY
3.1.1 LAMEA Glaucoma in Conjunction with Cataract Market by Country
3.1.2 LAMEA Stand Alone Glaucoma Market by Country
CHAPTER 4. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET
4.1.1 LAMEA Trabecular Meshwork Market by Country
4.1.2 LAMEA Suprachoroidal Space Market by Country
4.1.3 LAMEA Other Targets Market by Country
CHAPTER 5. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT
5.1.1 LAMEA MIGS Stents Market by Country
5.1.2 LAMEA MIGS Shunts Market by Country
5.1.3 LAMEA Other Products Market by Country
CHAPTER 6. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER
6.1.1 LAMEA Eye Hospitals Market by Country
6.1.2 LAMEA Ophthalmology Clinics Market by Country
6.1.3 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices in Other End User Market by Country
CHAPTER 7. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY
7.1 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.1.1 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.1.2 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.1.3 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.1.4 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.2 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.2.1 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.2.2 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.2.3 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.2.4 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.3 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.3.1 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.3.2 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.3.3 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.3.4 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.4 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.4.1 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.4.2 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.4.3 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.4.4 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.5 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.5.1 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.5.2 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.5.3 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.5.4 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.6 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.6.1 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.6.2 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.6.3 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.6.4 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.7 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.7.1 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.7.2 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.7.3 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.7.4 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
CHAPTER 8. COMPANY PROFILE
8.1 Ellex Medical Lasers Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Allergan Plc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.3 Santen Pharmaceutical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Novartis AG (Alcon Inc.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Lumenis Ltd.
8.6.1 Company Overview
8.7 iSTAR Medical
8.7.1 Company Overview
8.8 Ivantis, Inc.
8.8.1 Company Overview
8.9 SOLX, Inc.
8.9.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery
1.4.2 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Target
1.4.3 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
1.4.4 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End User
1.4.5 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Drivers, and Restraints
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY
3.1.1 LAMEA Glaucoma in Conjunction with Cataract Market by Country
3.1.2 LAMEA Stand Alone Glaucoma Market by Country
CHAPTER 4. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET
4.1.1 LAMEA Trabecular Meshwork Market by Country
4.1.2 LAMEA Suprachoroidal Space Market by Country
4.1.3 LAMEA Other Targets Market by Country
CHAPTER 5. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT
5.1.1 LAMEA MIGS Stents Market by Country
5.1.2 LAMEA MIGS Shunts Market by Country
5.1.3 LAMEA Other Products Market by Country
CHAPTER 6. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER
6.1.1 LAMEA Eye Hospitals Market by Country
6.1.2 LAMEA Ophthalmology Clinics Market by Country
6.1.3 LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices in Other End User Market by Country
CHAPTER 7. LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY
7.1 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.1.1 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.1.2 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.1.3 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.1.4 Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.2 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.2.1 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.2.2 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.2.3 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.2.4 Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.3 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.3.1 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.3.2 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.3.3 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.3.4 UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.4 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.4.1 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.4.2 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.4.3 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.4.4 Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.5 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.5.1 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.5.2 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.5.3 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.5.4 South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.6 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.6.1 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.6.2 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.6.3 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.6.4 Nigeria Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.7 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.7.1 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.7.2 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.7.3 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.7.4 Rest of LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
CHAPTER 8. COMPANY PROFILE
8.1 Ellex Medical Lasers Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Allergan Plc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.3 Santen Pharmaceutical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Novartis AG (Alcon Inc.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Lumenis Ltd.
8.6.1 Company Overview
8.7 iSTAR Medical
8.7.1 Company Overview
8.8 Ivantis, Inc.
8.8.1 Company Overview
8.9 SOLX, Inc.
8.9.1 Company Overview
LIST OF TABLES
Table 1 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 2 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 3 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 4 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 5 LAMEA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 6 LAMEA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 7 LAMEA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 8 LAMEA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 9 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 10 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 11 LAMEA TRABECULAR MESHWORK MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 12 LAMEA TRABECULAR MESHWORK MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 13 LAMEA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 14 LAMEA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 15 LAMEA OTHER TARGETS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 16 LAMEA OTHER TARGETS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 17 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 18 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 19 LAMEA MIGS STENTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 20 LAMEA MIGS STENTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 21 LAMEA MIGS SHUNTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 22 LAMEA MIGS SHUNTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 23 LAMEA OTHER PRODUCTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 24 LAMEA OTHER PRODUCTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 25 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 26 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 27 LAMEA EYE HOSPITALS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 28 LAMEA EYE HOSPITALS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 29 LAMEA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 30 LAMEA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 31 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 32 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 33 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 34 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 35 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 36 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 37 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 38 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 39 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 40 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 41 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 42 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 43 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 44 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 45 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 46 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 47 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 48 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 49 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 50 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 51 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 52 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 53 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 54 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 55 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 56 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 57 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 58 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 59 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 60 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 61 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 62 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 63 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 64 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 65 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 66 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 67 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 68 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 69 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 70 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 71 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 72 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 73 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 74 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 75 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 76 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 77 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 78 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 79 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 80 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 81 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 82 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 83 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 84 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 85 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 86 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 87 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 88 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 89 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 90 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 91 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 92 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 93 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 94 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 95 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 96 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 97 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 98 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 99 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 100 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 101 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 102 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 103 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 104 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 105 KEY INFORMATION – ELLEX MEDICAL LASERS LTD.
Table 106 KEY INFORMATION – ALLERGAN PLC.
Table 107 KEY INFORMATION – SANTEN PHARMACEUTICAL CO., LTD.
Table 108 KEY INFORMATION – GLAUKOS CORPORATION
Table 109 KEY INFORMATION – NOVARTIS AG (ALCON INC.)
Table 110 KEY INFORMATION – LUMENIS LTD.
Table 111 KEY INFORMATION – ISTAR MEDICAL
Table 112 KEY INFORMATION – IVANTIS, INC.
Table 113 KEY INFORMATION – SOLX, INC.
Table 1 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 2 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 3 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 4 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 5 LAMEA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 6 LAMEA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 7 LAMEA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 8 LAMEA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 9 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 10 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 11 LAMEA TRABECULAR MESHWORK MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 12 LAMEA TRABECULAR MESHWORK MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 13 LAMEA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 14 LAMEA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 15 LAMEA OTHER TARGETS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 16 LAMEA OTHER TARGETS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 17 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 18 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 19 LAMEA MIGS STENTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 20 LAMEA MIGS STENTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 21 LAMEA MIGS SHUNTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 22 LAMEA MIGS SHUNTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 23 LAMEA OTHER PRODUCTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 24 LAMEA OTHER PRODUCTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 25 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 26 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 27 LAMEA EYE HOSPITALS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 28 LAMEA EYE HOSPITALS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 29 LAMEA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 30 LAMEA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 31 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 32 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 33 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 34 LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 35 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 36 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 37 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 38 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 39 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 40 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 41 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 42 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 43 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 44 BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 45 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 46 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 47 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 48 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 49 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 50 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 51 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 52 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 53 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 54 ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 55 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 56 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 57 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 58 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 59 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 60 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 61 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 62 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 63 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 64 UAE MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 65 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 66 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 67 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 68 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 69 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 70 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 71 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 72 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 73 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 74 SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 75 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 76 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 77 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 78 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 79 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 80 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 81 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 82 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 83 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 84 SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 85 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 86 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 87 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 88 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 89 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 90 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 91 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 92 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 93 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 94 NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 95 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 96 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 97 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 98 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 99 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 100 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 101 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 102 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 103 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 104 REST OF LAMEA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 105 KEY INFORMATION – ELLEX MEDICAL LASERS LTD.
Table 106 KEY INFORMATION – ALLERGAN PLC.
Table 107 KEY INFORMATION – SANTEN PHARMACEUTICAL CO., LTD.
Table 108 KEY INFORMATION – GLAUKOS CORPORATION
Table 109 KEY INFORMATION – NOVARTIS AG (ALCON INC.)
Table 110 KEY INFORMATION – LUMENIS LTD.
Table 111 KEY INFORMATION – ISTAR MEDICAL
Table 112 KEY INFORMATION – IVANTIS, INC.
Table 113 KEY INFORMATION – SOLX, INC.
